Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Verona Pharma Plc ADR shares valued at $188,881 were purchased by EBSWORTH DAVID R on Nov 06 ’24. At $4.80 per share, EBSWORTH DAVID R acquired 39,360 shares. The insider’s holdings grew to 920,003 shares worth approximately $35.13 million following the completion of this transaction.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Also, ACKERMANN CHRISTINA purchased 41,880 shares, netting a total of over 198,386 in proceeds. Following the buying of shares at $4.74 each, the insider now holds 41,880 shares.
Before that, ZACCARDELLI DAVID had sold 94,144 shares from its account. In a trade valued at $413,462, the President and CEO traded Verona Pharma Plc ADR shares for $4.39 each. Upon closing the transaction, the insider’s holdings decreased to 94,144 shares, worth approximately $580.52 million.
As published in their initiating research note from Wells Fargo on October 03, 2024, Verona Pharma Plc ADR [VRNA] has been an Overweight and the price target has been revised to $50. Earlier on August 26, 2022, Piper Sandler initiated its rating. Their recommendation was “an Overweight” for VRNA stock.
Analyzing VRNA Stock Performance
During the last five days, there has been a surge of approximately 12.53%. Over the course of the year, Verona Pharma Plc ADR shares have jumped approximately 92.05%. Shares of the company reached a 52-week high of $39.40 on 11/05/24 and a 52-week low of $11.39 on 05/30/24. A 50-day SMA is recorded $31.50, while a 200-day SMA reached $21.01. Nevertheless, trading volume fell to 0.62 million shares from 1.02 million shares the previous day.
Support And Resistance Levels for Verona Pharma Plc ADR (VRNA)
According to the 24-hour chart, there is a support level at 37.03, which, if violated, would cause prices to drop to 35.87. In the upper region, resistance lies at 38.79. The next price resistance is at 39.40. RSI (Relative Strength Index) is 72.66 on the 14-day chart, showing overbought technical sentiment. Moving Average Convergence Divergence (MACD) is at 2.68, which suggests the price will increase in the coming days. Percent R is at 15.62%, indicating bullish price movement. Stochastics %K at selling indicates that the stock is to be held.
Which companies own the most shares of Verona Pharma Plc ADR (VRNA)?
On September 13, 2021, H.C. Wainwright assigned a price target of “a Buy” to the stock and initiated coverage with a $25.
